PTK2B variant linked to Alzheimer's risk impairs electrical activity and Tau processing in human neurons
A bioRxiv preprint identifies how the rs28834970 variant in PTK2B disrupts neuronal function and influences two hallmark Alzheimer's pathways in cultured human neurones.
A preprint posted to bioRxiv describes work characterising the functional consequences of rs28834970, a single-nucleotide variant in the PTK2B gene that genome-wide association studies have previously linked to Alzheimer's disease risk. PTK2B encodes Proline-rich tyrosine kinase 2 (PYK2), a signalling protein implicated in synaptic function, but its precise contribution to Alzheimer's disease aetiology has remained disputed owing to contradictory evidence regarding amyloid-beta toxicity, tauopathy, and neuronal dysfunction.
The authors combined in silico variant-effect prediction with luciferase reporter assays and human neuronal culture models to investigate whether rs28834970 is likely to be the causal variant among associated PTK2B signals, and to determine how it impairs PYK2 function. Their experiments indicate that the variant reduces neuronal electrical activity and alters both Tau phosphorylation and amyloid precursor protein (APP) processing — two processes central to established models of Alzheimer's pathology.
The study has not yet been peer-reviewed and should be interpreted accordingly. Nonetheless, it contributes mechanistic detail to the genetics of a GWAS locus that has so far resisted functional explanation. Researchers working on neurodegeneration, synaptic signalling, or the functional interpretation of non-coding GWAS variants may find the methodology and findings of interest. The work does not assess clinical outcomes and no therapeutic implications are discussed by the authors.
Plain-language version
For patients, families, and general readers. Educational only — not medical advice.
Scientists studying Alzheimer's disease have published early-stage research — not yet checked by independent reviewers — looking at a specific genetic variant called rs28834970 in a gene known as PTK2B. This gene makes a protein involved in how brain cells communicate with one another. In laboratory-grown human brain cells, the researchers found that this variant appeared to affect electrical activity in the cells and to influence two processes that have long been associated with Alzheimer's disease: the build-up of a protein called Tau and the processing of another protein linked to amyloid plaques. The research is at a very early stage and does not tell us anything about individual risk or what any person should do. It adds to scientific understanding of why certain genetic variants spotted in large population studies might be connected to Alzheimer's disease. This is an educational summary, not medical advice. If anything here raises questions for you, please speak with your GP or a clinical professional.
Sources
Read the original reporting — these are the public sources this summary draws from.
-
Primary sourcePreprint bioRxiv (Cold Spring Harbor Laboratory) · 2026-10-30The Alzheimer's disease-associated rs28834970 variant in PTK2B impairs electrical activity and regulates Tau phosphorylation and APP processing in human neuronal cultures